CAS: 384859-58-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 2-((3-(Ethoxycarbonyl)-6-(trifluoromethoxy)quinolin-4-yl)amino)benzoic acid REF: IN-DA01KKVBCAS: 384859-58-9 | 98% | To inquire | Tue 07 Jan 25 |
 | BCH001 REF: TM-T8647CAS: 384859-58-9 | 99.06% | 51.00 €~417.00 € | Tue 14 Jan 25 |
 | BCH001 REF: 3D-JQA85958CAS: 384859-58-9 | Min. 95% | To inquire | Tue 18 Feb 25 |
2-((3-(Ethoxycarbonyl)-6-(trifluoromethoxy)quinolin-4-yl)amino)benzoic acid
CAS:384859-58-9
Formula:
C20H15F3N2O5
Purity:
98%
Molecular weight:
420.3387
Ref: IN-DA01KKVB
| 25mg | 173.00 € | ||
| 100mg | 582.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
BCH001
CAS:384859-58-9
BCH001 is a specific small-molecule inhibitor of PAPD5.
Formula:
C20H15F3N2O5
Purity:
99.06%
Color and Shape:
Solid
Molecular weight:
420.34
Ref: TM-T8647
| 5mg | 51.00 € | ||
| 10mg | 78.00 € | ||
| 25mg | 150.00 € | ||
| 50mg | 269.00 € | ||
| 100mg | 417.00 € | ||
| 1mL*10mM (DMSO) | 53.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
BCH001
CAS:384859-58-9
BCH001 is a cell-based therapy that is indicated for use in neonates with congenital heart …
Formula:
C20H15F3N2O5
Purity:
Min. 95%
Molecular weight:
420.3 g/mol
Ref: 3D-JQA85958
| 100mg | 1,116.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
